A Q&A page on COVID-19 and breastfeeding.
Concerns have been raised that NSAIDs may be associated with an increased risk of adverse effects when used in patients with acute viral respiratory infections, including COVID-19.1,2 This review aimed to assess the effects of prior and current use of NSAIDs in patients with acute viral respiratory infections on acute severe adverse events (including mortality, the acute respiratory distress syndrome (ARDS), acute organ failure, and opportunistic infections), on acute health care utilization (including hospitalization, intensive care unit (ICU) admission, supplemental oxygen therapy, and mechanical ventilation) as well as on quality of life and long-term survival.
The document updates WHO’s 2005 guidance on blood pressure measuring devices (BPMDs). It also responds to concern about the lack of accurate, good-quality devices, especially in low-and middle-income countries (LMIC) through technical consultation and expert review. The focus of the publication is on automated non-invasive BPMDs with cuff, including characteristics, regulatory requirements and standards, calibration as well as maintenance. It also provides guidance on procurement, decontamination and decommissioning. Additional elements on accurate measurement of BP and training for personnel are included.
This new HEARTS – D module on Diagnosis and management of type 2 diabetes complements and expands the diabetes section of the HEARTS Technical Package developed for use in primary health-care facilities to improve cardiovascular health. This module brings together WHO guidance on diagnosis, classification and management of type 2 diabetes in one document. It is aligned with the WHO Package of Essential Noncommunicable Disease Interventions in Primary Health Care (WHO-PEN) and can be used independently or in conjunction with the other modules of the HEARTS technical package.
People with underlying noncommunicable diseases (NCDs) such as hypertension, diabetes, cardiovascular disease, chronic respiratory disease and cancer have a high risk for developing severe and even fatal COVID-19. It is important for them to strictly follow basic protective measures and make sure their chronic diseases are well managed. However, pandemics cripple health systems and compromise provision routine medical care. This technical note gives general guidance to people living with NCDs, their caregivers and family members, the public, health programme managers and health-care workers on how to reduce risks of a COVID-19 infection and maintain care for people living with NCDs during the outbreak.
Facing the COVID-19 (new coronavirus disease) pandemic, the countries of the world must take decisive action to stop the spread of the virus. In these critical circumstances, it is essential that everyone is informed about other health risks and hazards so that they can stay safe and healthy.
This strategic preparedness and response plan outlines the public health measures that the international community stands ready to provide to support all countries to prepare for and respond to COVID-19.
Note: This guidance is aimed at individuals and families in contexts where self-quarantine and isolation have been recommended or required.
As countries are taking stronger measures to contain the spread of COVID-19, self-quarantine and the temporary closing of businesses may affect normal food-related practices. Healthy individuals, as well as those showing acute respiratory disease symptoms, are being requested to stay at home. In some countries, restaurants and take-away offers are being limited and some fresh items are becoming less available
A central database of Country & Technical Guidance on Coronavirus disease (COVID-19) from the World Health Organization. Please note that this database will be continually updated as new information and guidance is made available.
Pulmonary Vascular Research Institute (PVRI) has an interactive learning platform that allows users to acquire knowledge on all PVRI related subjects.
Published by: Pulmonary Vascular Research Institute (PVRI)
Our medical experts help explain what we know so far about the Covid-19 coronavirus and how it can affect people with heart disease. Are people with heart and circulatory disease at increased risk of coronavirus? The majority of people diagnosed with coronavirus (Covid-19) have mild symptoms and make a full recovery. However, early indications are that people with heart and circulatory diseases are at risk of a more severe illness which could require admission to hospital.
Published by: British Heart Foundation
As new COVID-19 cases continue to emerge in the WHO European Region, many healthy individuals are being requested to stay at home in self-quarantine. In some countries, fitness centres and other locations where individuals are normally active, will remain temporarily closed. Staying at home for prolonged periods of time can pose a significant challenge for remaining physically active. Warning: This guidance is intended for people in self-quarantine without any symptoms or diagnosis of acute respiratory illness. It should not replace medical guidance in case of any health condition.
The World Heath Organization published 6 mental health and psychosocial support coping strategies to help children to deal with the stress which may arise as a result of the 2019-nCoV outbreak.
Ari - Virtual Assistant